Viatris Inc. (VTRS)
NASDAQ: VTRS · Real-Time Price · USD
14.89
-0.81 (-5.16%)
At close: Mar 3, 2026, 4:00 PM EST
14.89
0.00 (0.00%)
Pre-market: Mar 4, 2026, 8:20 AM EST
Viatris Employees
Viatris had 30,000 employees as of December 31, 2025. The number of employees decreased by 2,000 or -6.25% compared to the previous year.
Employees
30,000
Change (1Y)
-2,000
Growth (1Y)
-6.25%
Revenue / Employee
$476,663
Profits / Employee
-$117,163
Market Cap
17.14B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 30,000 | -2,000 | -6.25% |
| Dec 31, 2024 | 32,000 | -6,000 | -15.79% |
| Dec 31, 2023 | 38,000 | 1,000 | 2.70% |
| Dec 31, 2022 | 37,000 | 0 | - |
| Dec 31, 2021 | 37,000 | -8,000 | -17.78% |
| Dec 31, 2020 | 45,000 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| Takeda Pharmaceutical Company | 47,455 |
| Teva Pharmaceutical Industries | 33,950 |
| Dr. Reddy's Laboratories | 27,811 |
| Haleon | 24,561 |
| Zoetis | 14,500 |
| Elanco Animal Health | 9,900 |
| Alkermes | 2,050 |
| Neurocrine Biosciences | 2,000 |
VTRS News
- 22 hours ago - These S&P 500 stocks are falling the hardest on Tuesday - Market Watch
- 4 days ago - AI Is Sliding and Everything Else Has Run Up. Here Are 6 Stocks That Look Like Buys. - Barrons
- 5 days ago - Viatris Inc. (VTRS) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 6 days ago - Viatris forecasts 2026 profit below estimates on India manufacturing woes - Reuters
- 6 days ago - Viatris Reports Fourth-Quarter and Full-Year 2025 Financial Results - PRNewsWire
- 6 days ago - Viatris Maintains Dividend Policy for 2026 and Announces Quarterly Dividend - PRNewsWire
- 7 days ago - FDA Accepts Viatris Supplemental New Drug Application for MR-141 (Phentolamine Ophthalmic Solution 0.75%) for the Treatment of Presbyopia - PRNewsWire
- 11 days ago - Viatris: Deep-Value Pharma With Emerging Growth Catalysts And Strong Cash Generation - Seeking Alpha